Biggest News Aggregation in the World
📰 D News

Page 1112 - D News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from D. Real-time updates on events, politics, business and more.

'Pacemaker': A Trans-Positive Story of Hope and Acceptance

Christopher Lennertz’s 3DCG heartfelt short about a grandfather’s journey to understand his grandson’s message of love and pride stars 2023 Tony Award winner Alex Newell, the first-ever non-binary actor to win a Tony, and multi-Grammy Award winner Philip Lawrence, with ‘Nimona’s ND Stevenson serving as executive producer. 
City Of United Kingdom Darlene Caama Nicholas Gustafson Alex Bedford Google Jamboard
Source: awn.com

Addition of Bridging Therapy to Axi-Cel Produces Comparable Real-World Outcomes in R/R LBCL

Although the use of bridging therapy prior to treatment with axicabtagene ciloleucel did not improve efficacy or safety outcomes for patients with relapsed/refractory large B-cell lymphoma, responses to bridging therapy may be prognostic of favorable outcomes after axi-cel administration.
United States University Of Pennsylvania Michaelr Cook Marrow Transplant Research Perelman School Of Medicine International Blood

2016 Toppers Scam Case: ED seizes Rs 3 cr cash, 80 property docus

After conducting searches at multiple locations in Bihar, the Enforcement Directorate (ED) has seized more than Rs 3 crore in cash and over 80 property documents related to Bachcha Rai aka Amit Kumarthe, the main accused in the 2016 toppers scam case, sources said. The ED team came into action following the reports of fresh construction work in the premises of Rai, which were
New Delhi Amit Kumarthe Saurabh Shrestha Rahul Kumar Ruby Rai Bachcha Rai

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Venetoclax Is Associated With Durable ORRs in Real-World Population of BTK Inhibitor–Exposed CLL/SLL

Venetoclax-based therapy generated durable responses both overall and in the second or third line following covalent BTK inhibitor discontinuation in real-world patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
North Carolina United States Nilanjan Ghosh Department Of Hematologic Oncology Hematologic Oncology Blood Disorders

Retrospective Analysis Supports Utilization of Auto-HCT in Relapsed LBCL Achieving a CR

Autologous hematopoietic cell transplantation lowered relapse and progression rates and improved survival outcomes vs CAR T-cell therapy in patients with relapsed large B-cell lymphoma who experienced complete remission with interim treatment.
Mazyar Shadman Marrow Transplant Research International Blood Fred Hutch Cancer Center Clinical Research Division Innovators Network

Dr Andrew Srisuwananukorn on the Potential for AI in Differentiating prePMF and ET

Andrew Srisuwananukorn, MD, of the Ohio State University Comprehensive Cancer Center, explained the potential of artificial intelligence (AI)-based support tools for differentiating primary myelofibrosis (prePMF) and essential thrombocythemia (ET) in the community setting.
United States Andrew Srisuwananukorn Ohio State University Comprehensive Cancer Center American Society Of Hematology Annual Meeting Hematology Annual Meeting Primary Myelofibrosis
Source: ajmc.com

Adding Navitoclax to Ruxolitinib Doubles Spleen Volume Reductions for Myelofibrosis

Up-front treatment with navitoclax plus ruxolitinib significantly reduced spleen volume by 35% or more at week 24 vs ruxolitinib plus placebo in patients with myelofibrosis; however, a significant difference was not observed in total symptom score v. 4.0 between the arms, according to data from the phase 3 TRANSFORM-1 study.
United States Naveen Pemmaraju Department Of Leukemia University Of Texas Md Anderson Cancer Center Cancer Center Navitoclax Plus Ruxolotinib

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science